Aerocrine and Chest sign distribution agreement
Chest will apply for market authorization of Niox Mino in Japan and then proceed to product launch. Niox Mino is a handheld device that in a couple of
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.